SCHEMBL6567369

SCHEMBL6567369

CC(C)(C)c1cccc(CCCCO)c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.53
GABRA1 P14867 2/20 0.47
GABRB2 P47870 2/20 0.47
ATM Q13315 1/20 0.43
ALOX5 P09917 1/20 0.41
PTGS2 P35354 1/20 0.41
ALOX12 P18054 1/20 0.40
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
IAPP P10997 4/20 0.36
HSPA5 P11021 2/20 0.36
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35
BID P55957 1/20 0.33
BCL2L1 Q07817 1/20 0.33
MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568673 0.98 CA2 (0.52) CA2GABRA1GABRB2ATMALOX5
SCHEMBL6568762 0.98 CA2 (0.52) CA2GABRA1GABRB2ATMALOX5
SCHEMBL6567771 0.95 CA2 (0.55) CA2GABRA1GABRB2ATMALOX5
SCHEMBL3809080 0.87 CA2 (0.59) CA2GABRA1GABRB2ATMALOX12
SCHEMBL8319104 0.86 ALOX5 (0.57) CA2GABRA1GABRB2ATMALOX5
SCHEMBL28387663 0.85 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2
SCHEMBL8326910 0.85 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2
SCHEMBL11226955 0.85 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2
SCHEMBL9352402 0.85 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2
SCHEMBL11021636 0.85 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1572795-A Process for producing phosphite SUMITOMO CHEMICAL CO (JP) 2005-02-02 CN disclosed
EP-1484334-A2 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-08 EP disclosed
US-20040225145-A1 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED 2004-11-11 US disclosed
EP-0823435-B1 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL CO (JP) 2001-11-21 EP disclosed
US-6242514-B1 CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2001-06-05 US disclosed
US-5914361-A IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-06-22 US disclosed
US-5889095-A OXYGEN AND HEAT RESISTANCE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1999-03-30 US disclosed
EP-0823435-A2 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-02-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040225145-A1 Process for producing phosphite PHOSPHO1, PLCG1, PLCG2 CA2 167/4885GABRA1 4615/4885GABRB2 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.